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Heavy Menstrual Bleeding (HMB) is common and existing
treatments often ineffective. The MRC funded DexFEM
trial aims to investigate whether oral dexamethasone (Dex;
a glucocorticoid) reduces HMB.
Our integrated approach to the development of a
Bayesian response-adaptive dose-finding study uses SAS
for data handling, generating scripts and executing ana-
lysis in WinBUGS. The clinical aims are twofold: (i) to
determine if Dex is efficacious in reducing HMB com-
pared with placebo and, if so, (ii) to identify the optimal
dose for further phase III study. Patients are randomised
to placebo or one of several active Dex doses. Randomi-
sation probabilities change as outcome data accumulate
from patients already recruited. This design ensures that
maximum information is gathered on the dose-response
curve, and also that fewer women are randomised to
inferior doses. Development of an adaptive design can-
not invoke standard frequentist concepts of power. We
estimate the dose-response curve in a Bayesian Normal
Dynamic Linear Model.
Several competing design options are considered
including: the number of doses; the criterion for adapt-
ing the randomisation; the length of the run-in before
adaptation commences; the frequency with which ran-
domisation probabilities are adapted. Through extensive
simulation work we assess the performance of candidate
designs under a variety of plausible scenarios for dose-
response curve shape and outcome measure variance,
and decide on a final design. Adaptive designs offer flex-
ibility and efficiency and are likely to be used more in
the future. Our integrated approach is a practical,
powerful tool for the development of such designs.
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